Seer, Sciex to provide end-to-end proteomics solutions

By The Science Advisory Board staff writers

March 30, 2021 -- Sciex and Seer have inked a nonexclusive commercial agreement. Under the deal, Seer will market Sciex's mass spectrometry systems together with its Proteograph product suite.

The firms believe that the combination will yield end-to-end proteomics workflows for labs of all types. Seer's Proteograph product suite includes proprietary engineered nanoparticles, consumables, an automation instrument, and software that enables proteomics studies.

Adding Sciex systems will bring new options for customers to add unbiased proteomics analysis to their studies, according to the companies. Existing proteomics labs can also expand their application set with the combined offering, Seer and Sciex said.

Sciex acquires Intabio
Sciex has acquired Intabio, developer of the Blaze system for biotherapeutic analysis and quality assessment. The Blaze system enables direct coupling...
Sciex, 908 Devices launch biotherapeutics characterization platform
Sciex and 908 Devices have made the ZipChip platform for Sciex mass spectrometers available to the public. This platform expands mass spectrometers from...

Copyright © 2021

Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter